[Ophthalmic preparations Polyspectran (combination of neomycin, polymyxin B and bacitracin/gramicidin) and Terramycin (oxytetracycline with polymyxin B) mistakenly no longer reimbursed]

Ned Tijdschr Geneeskd. 1997 Jan 25;141(4):204-5.
[Article in Dutch]

Abstract

The Netherlands' Ministry of Health and the health insurance companies have drawn up a list of preparations which will no longer be reimbursed. The ocular antibiotic preparations Polyspectran and Terramycin are on the list. However, there are no satisfactory alternative with respect to the broadness of the antibiotic spectrum required. In addition, some alternatives have serious side effects or may induce bacterial resistance.

MeSH terms

  • Anti-Bacterial Agents / economics
  • Bacitracin / economics
  • Drug Therapy, Combination / administration & dosage
  • Drug Therapy, Combination / economics*
  • Gramicidin / economics
  • Humans
  • Insurance, Health, Reimbursement*
  • Neomycin / economics
  • Netherlands
  • Ophthalmic Solutions / economics*
  • Oxytetracycline / economics
  • Polymyxin B / economics

Substances

  • Anti-Bacterial Agents
  • Ophthalmic Solutions
  • Bacitracin
  • Gramicidin
  • Neomycin
  • Polymyxin B
  • Oxytetracycline